Clinical Trials Logo

Sacroiliitis clinical trials

View clinical trials related to Sacroiliitis.

Filter by:

NCT ID: NCT05520463 Completed - Back Pain Clinical Trials

Fluoroscopy Versus Ultrasound Guidance for Sacral Lateral Branch Radiofrequency Ablation

Start date: September 1, 2022
Phase: N/A
Study type: Interventional

Sacroiliac joint is a diarthroidal and synovial joint that receives sensory innervatin by the sacral lateral branches ( commonly S1-3, with variable contributions from L5 dorsal ramus and S4 lateral branch). Sacral lateral branch radiofrequency ablation and block techniques are widely used for the management of sacroiliac joint pain. With the increasing use of ultrasound technology in pain medicine, the ultrasound guided approaches gained popularity. To our knowledge, there are no randomized controlled trials comparing the ultrasound and fluoroscopy approaches for sacral lateral branch radiofrequency ablation. This study aims to compare the ultrasound and fluoroscopy guidance techniques for sacral lateral branch radiofrequency ablation.

NCT ID: NCT05396495 Recruiting - Sacroiliitis Clinical Trials

Safety and Feasibility of the NeurolyserXR for Sacroiliac Joint Pain

Start date: October 24, 2022
Phase: N/A
Study type: Interventional

Pilot study to evaluate the safety and the effectiveness of the Neurolyser XR as a treatment for sacroiliitis

NCT ID: NCT05276024 Recruiting - Spine Deformity Clinical Trials

Evaluation of the iFuse Bedrock Technique in Association With Posterior Lumbosacral Fusion With Iliac Fixation.

Start date: June 10, 2022
Phase:
Study type: Observational

The purpose of this study is to describe the impact of the iFuse Bedrock technique to decrease post-operative pains in patients who underwent multilevel posterior lumbosacral fusion.

NCT ID: NCT05203926 Enrolling by invitation - Sacroiliitis Clinical Trials

Significance and Outcome of Magnetic Resonance Enterography Revealing Sacroiliitis in Crohn's Disease: A Pilot Study

Start date: March 14, 2022
Phase: N/A
Study type: Interventional

This study aims to further define and characterize imaging findings of possible sacroiliitis in Crohn's Disease patients by recalling subjects who had findings of possible sacroiliitis on prior MRE and assess the natural history and outcome of these cases by using standard magnetic resonance imaging (MRI) and x-ray of the sacroiliac joints.

NCT ID: NCT05134181 Recruiting - Clinical trials for Sacroiliac Joint Arthritis

Ultrasound Guided Intra-sacroiliac Joint Injection: Methylprednisolone Versus Triamcinolone

Start date: August 1, 2021
Phase: Phase 2
Study type: Interventional

Intra-articular steroids have been also practiced since a long time. These agents have a better and safer profile as compared to oral drugs in terms of adverse effects/contraindications of the later. Moreover, Intra-articular steroids impart a better pain relief by delivering and also delays any surgical intervention thereby improving the patient's quality of life. Without imaging, intra-articular injection has been shown in only 22% of patients so ultrasound, fluoroscopic imaging and computerized tomographic (CT) are required to ensure accuracy. Comparing to other guidance, ultrasound guided injection provides easy, safe, accurate, non-invasive, inexpensive imaging and lacking exposure to radiation.

NCT ID: NCT04329182 Not yet recruiting - Clinical trials for Active Sacroiliitis in Ankylosing Spondylitis

Color Doppler Ultrasonography in Evaluation of Active Sacroiliitis in Ankylosing Spondylitis

Start date: May 2020
Phase:
Study type: Observational

Evaluate the role of color Doppler ultrasonography (CDUS) in detection of active sacroiliitis in Ankylosing Spondylitis patients using MRI of the sacroiliac joints as a gold standard. Evaluate the relation of active sacroiliitis detected by color Doppler ultrasonography (CDUS) with disese activity in patients with ankylosing spondylitis

NCT ID: NCT04314609 Completed - Sacroiliitis Clinical Trials

Success Rate of Ultrasound Guided Sacroiliac Joint Injection in Sacroiliitis

Start date: October 1, 2019
Phase: N/A
Study type: Interventional

To re-investigate the success rate of Ultrasound guided sacroiliac joint steroid injection in depositing the drug inside the joint capsule (confirmed by contrast spread in fluoroscopy) and if there is a difference in clinical outcome between injections done strictly inside the joint and injections done periarticular.

NCT ID: NCT03992053 Withdrawn - Sacroiliitis Clinical Trials

Imaging for SIJ Injection Therapy

Start date: May 31, 2019
Phase: N/A
Study type: Interventional

The Research question: Among two standard image guidance techniques [2-dimension (2-D) conventional Fluoroscopy Versus 3-dimension (3-D) Cone-Beam Computed Tomography (CBCT)], which is the better guidance for Sacroiliac Joint Injection therapy and should be used first? The specific aims: To detect the difference of the first-time success rate, the cross-over rate, the procedural time, the radiation exposure, the incidence of adverse events/complications, and overall satisfaction score between the 2-D Fluoroscopy versus 3-D CBCT guidance for SIJ injection.

NCT ID: NCT03834480 Completed - Sacroiliitis Clinical Trials

Intraartecular Platelet Rich Plasma for Sacroiliitis

Start date: December 1, 2017
Phase: N/A
Study type: Interventional

Comparison between the effect of steroids and platelet-rich plasma on low back pain after ultrasound-guided sacroiliac injection to determine any is more effective and of long duration

NCT ID: NCT03744234 Completed - Clinical trials for Sacroiliac Joint Arthritis

Platelet-rich Plasma in the Sacroiliac Joint

Start date: December 1, 2016
Phase: N/A
Study type: Interventional

This is a double-blinded study where the injecting physicians and the patients will not know which arm they are randomized to. Each participant will be followed up for 6 months following the injection, and will have in office visits at the injection and approximately 2 weeks post injection. They will be called at month 1, 3, and 6 post injection to assess for any adverse events and number of physical therapy hours or changes in medication. At time of injection, 2 weeks post, and 1, 3 and 6 months after they will be asked to answer some questionnaires on pain and function.